
Psilocybin and Cluster Headaches: What the Research Says
By Lily Pelenis / November 20, 2026 / 8 min read
Have you ever joked that a mushroom trip cleared your head? For psilocybin and cluster headaches, small clinical trials suggest fewer attacks in some people, but the results are early, mixed and far from proof. No psilocybin product is approved for any headache in Canada, so this piece is about what the research found, not a plan for your next attack. If you live with cluster headache or migraine, your doctor or a headache specialist is the person to bring this to.
TLDR
Cluster headache is a rare, one-sided and severe pain disorder. For decades, patients have reported that psilocybin cut attacks short or ended a cluster period. Those reports led to trials, and the trials so far are tiny: 10 to 16 people each.
In the first placebo-controlled trial, attack frequency dropped more with psilocybin, but the difference was not statistically significant. A repeat round in 10 people roughly halved weekly attacks, with no placebo group that time. A Danish open-label study of 10 people found a 31% average drop.
A 2025 study of 11,419 people in Britain found that people who had ever used psychedelics were a quarter less likely, in odds terms, to report frequent bad headaches. That is a link, not a cause. Triptans, antidepressants, lithium and heart conditions all need a doctor’s view first.
Quick facts
- 22 of 26
- users in a 2006 report said attacks stopped
- 10 to 18
- people in each clinical trial so far
- 25% lower
- odds of frequent bad headaches, users
- 0
- psilocybin products approved in Canada
Who this article is for
- You live with cluster headache and keep hearing about psilocybin in patient groups.
- You get migraines and wonder whether the research applies to you.
- You use mushrooms and want to know how they mix with triptans or other headache medicines.
- You care for someone with cluster headache and want facts before the next conversation.
Lily Pelenis
Author’s note
This piece began as a letter to our newsletter readers in April 2025. That letter covered two new studies, one on Parkinson’s disease and one on headaches. I have written about the Parkinson’s research before, so here I stay with the headaches.
I am a Toronto-based lifestyle coach and yoga instructor, and I have used psilocybin for over a decade. Headache research fascinates me because the patients led it. People in pain shared notes with each other for years, and scientists only caught up later. That deserves respect, and so does the gap between a patient report and a proven treatment.
What is a cluster headache?
A cluster headache is a rare headache disorder with attacks of severe pain on one side of the head. A 2025 review in The Journal of Headache and Pain describes the pain as excruciating and strictly one-sided, with a heavy toll on quality of life, work and social life.
Why patients went looking
The same review notes that many people do not respond to standard medicines, and much of the evidence for other options comes from those people. When nothing on the shelf works, people look further. I understand that, and I also want anyone in that place to have the real numbers.
What does research say about psilocybin and cluster headaches?
Patient surveys report strong benefits, while the controlled trials show smaller and less certain effects. I think both are worth knowing, because they answer different questions.
What patients reported
In 2006, Sewell, Halpern and Pope interviewed 53 people with cluster headache who had used psilocybin or LSD. Of 26 psilocybin users asked about it, 22 said it stopped attacks. Of 48, 25 said it ended a cluster period.
A larger survey run with the patient group ClusterBusters, published by Schindler and colleagues (2015), included 496 people. They rated psilocybin and LSD as good as or better than most standard medicines, even at doses too low to cause a trip. These are self-reports from people who chose to answer, so they lean toward good news.
In Canada, a poster at the 2025 American Headache Society meeting, reported by NeurologyLive, looked at the Canadian Psychedelic Survey. Of 2,393 people, 64 used psychedelics for headache, and psilocybin was the one most often named as most effective.
What the controlled trials found
At Yale, Schindler and colleagues (2022) gave three low doses of psilocybin, about five days apart, or a placebo. Of 16 people, 14 were analyzed. Attacks fell by 3.2 a week with psilocybin and barely moved with placebo, but the gap was not statistically significant. The effect looked larger in people with the chronic form.
Ten people came back at least six months later for a second round (2024). Weekly attacks fell from 18.4 to 9.8 in the three weeks after, with no placebo group. In Denmark, Madsen and colleagues (2024) gave 10 people with chronic cluster headache three doses in an open-label study. Attacks dropped 31% on average, and one person had 21 weeks free of attacks.
| Study | People | Design | What changed |
|---|---|---|---|
| Sewell et al., 2006 | 53 | Interviews of self-users | 22 of 26 said attacks stopped |
| Schindler et al., 2015 | 496 | Online patient survey | Rated equal to or better than most medicines |
| Schindler et al., 2022 | 14 analyzed | Placebo-controlled | Fewer attacks, not statistically significant |
| Schindler et al., 2024 | 10 | Repeat round, no placebo | 18.4 to 9.8 attacks a week |
| Madsen et al., 2024 | 10 | Open-label | 31% fewer attacks on average |
In the only placebo-controlled cluster headache trial, attacks fell more with psilocybin, but with 14 people the difference could still be chance.
Does psilocybin help migraine?
One tiny trial found fewer migraine days after a single dose, and a newer one found a similar drop with a placebo pill. To me, the question is still open.
The first migraine trial
In 2021, Schindler and colleagues gave 10 adults with migraine one dose of psilocybin and one placebo, two weeks apart. In the two weeks after psilocybin, migraine days fell by 1.65 a week, against 0.15 after placebo. The drop did not depend on how strong the trip felt.
The newer trial and the placebo problem
In a 2026 follow-up, 18 adults got one dose, two doses or none. The placebo was diphenhydramine, an antihistamine that makes people feel something. All groups saw migraine days fall by about half over eight weeks, and the differences were not statistically significant. The authors say the placebo partly passed for psilocybin, which made it hard to separate drug from expectation. My piece on placebo and blinding in psilocybin trials explains why this keeps happening.
Are people who use psychedelics less likely to get headaches?
In one large British study, they were somewhat less likely to report frequent bad headaches, but the study cannot say why. I read it as a reason for more research, not a reason to start using.
The study of 11,419 people
Bjurenfalk and colleagues (2025) used data from the 1958 British National Child Development Study, collected in 1999 and 2000. People who had ever used a classic psychedelic had 25% lower odds of frequent bad headaches, after the authors adjusted for other factors. According to PsyPost, women who had used psychedelics had 30% lower odds, while the result in men was not statistically significant.
Why it is only a link
People answered yes or no to whether they often had bad headaches. No doctor diagnosed them, and the study could not tell migraine from tension headaches. One possibility the authors raise is simple: people with frequent bad headaches may avoid psychedelics in the first place.
In a study of 11,419 people in Britain, those who had ever used a psychedelic had 25% lower odds of frequent bad headaches, and nobody yet knows why.
What are the risks, and which medications matter?
Psilocybin can cause headaches itself, it raises blood pressure, and it mixes badly with some common medicines. I would bring all of this to my doctor before anything else, and I hope you will too.
Psilocybin can trigger headaches
In a Johns Hopkins study of 18 healthy volunteers, Johnson and colleagues (2012) found that psilocybin often caused headaches that started late, grew with the dose and were gone within a day. They were not severe or disabling.
Triptans and other headache medicines
Triptans such as sumatriptan narrow blood vessels. The Yale cluster headache trial, as listed on ClinicalTrials.gov, excluded anyone who had used blood vessel narrowing medicines such as sumatriptan within five half-lives of a dosing day. It also excluded people who had taken antidepressants in the past six weeks, and people with serious heart disease. The Danish trial excluded people with high blood pressure or a heart attack or stroke in the past year.
Health Canada notes that magic mushrooms raise heart rate and blood pressure, which could be harmful for people with heart disease. In reports reviewed by Nayak and colleagues (2021), 47% of 62 cases of psychedelics with lithium involved seizures. A 2022 review found serotonin toxicity mostly with MAOI antidepressants, and SSRIs often weaken psilocybin’s effects.
Lily’s take
If you live with cluster headache, I would rather see you in a clinical trial than experimenting alone. The trials screen your heart and your medications first, and that screening is the part people skip.
What is legal in Canada
Health Canada says no psilocybin product is approved, and that clinical trials are the main legal route. A doctor can request access through the Special Access Program for serious conditions when usual treatments have failed or do not suit. These federal rules work the same way in Kingston as anywhere else in the country.
Try this
- Keep a headache diaryLog every attack for two weeks, as the trials did.
- List every medicineWrite down triptans, preventives, antidepressants and anything for your heart.
- See a specialistAsk your doctor for a referral to a headache clinic.
- Ask about trialsAsk whether a trial or the Special Access Program could fit you.
If you use mushrooms for other reasons
If you already use mushrooms as an adult and also live with headaches, tell your doctor, and never mix them with triptans on your own. Our dosing guide sets out six levels in grams, starting with a microdose of 0.1 to 0.25 g. I like measured formats because there is no guessing: each Golden Teacher Gummies for Microdosing piece equals 100 mg of mushroom, and Dried Golden Teacher Magic Mushrooms sit in the middle of our potency scale. If you are older, read my notes on how age changes a psilocybin experience too.
FAQ
Is psilocybin legal for cluster headaches in Canada?
No psilocybin product is approved for any condition in Canada. Clinical trials are the main legal route, and a doctor can apply to Health Canada’s Special Access Program for a patient with a serious condition when standard options have failed.
Can magic mushrooms give you a headache?
Yes. In a Johns Hopkins study of 18 healthy volunteers, psilocybin often caused headaches that started hours later, grew with the dose and lasted no more than a day.
Can you take psilocybin with triptans?
Ask your doctor; there is little data on the mix. The Yale cluster headache trial excluded people who had used blood vessel narrowing medicines such as sumatriptan within five half-lives of a dosing day.
Does microdosing help migraines?
I know of no controlled trial that has tested microdosing for migraine. The migraine trials used a single low but noticeable dose, and in the newest one a placebo pill did about as well.
Find your strain, then your dose
Every product on the shelf shows its potency rating and the effects people report. The dosing guide walks through amounts before you order, and a real person answers if you write to us.
About the author
Lily Pelenis
I'm a Toronto-based lifestyle coach, psilocybin enthusiast and certified yoga instructor. I guide people toward mindful, balanced living, and my coaching blends modern wellness practices with ancient wisdom to help clients find deeper self-awareness, resilience and joy.
I've been experimenting with shrooms for over a decade, and I write about my own experience. I love nature, psychology and humans. That is why my articles tend to follow a trip past its peak and into the weeks after it.
Some pieces start with a strain I have tried myself, such as Golden Teacher or Albino Roller Coaster. Others are the practical ones, like how much to take the first time or how to brew a tea that sits easier on the stomach. Over the years I've learned that intention is everything, so I write about why you are taking it before I get to how.
50% off your first order
New strains, restocks, sales and new writing from the Notebook, by email. No spam, unsubscribe any time.









